Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00555113
What this trial is testing

Evolution of Visual Impairment During Pseudoxanthoma Elasticum

Who this might be right for
Pseudoxanthoma Elasticum
European Georges Pompidou Hospital 38
Not applicableLooking for participantsNCT06435000
What this trial is testing

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

Who this might be right for
StargardtStargardt's DiseaseStargardt Disease+1 more
Splice Bio 75
Not applicableStudy completedNCT05904444
What this trial is testing

The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Who this might be right for
Macular DegenerationLow VisionStargardt Disease
Aier Eye Hospital, Guangzhou 29
Not applicableStudy completedNCT01837901
What this trial is testing

Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Okuvision GmbH 88
Not applicableStudy completedNCT06368375
What this trial is testing

Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
University Hospital Tuebingen 87
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05481827
What this trial is testing

ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

Who this might be right for
Age Related Macular Degeneration (AMD)
Gyroscope Therapeutics Limited 225
Not applicableLooking for participantsNCT04420156
What this trial is testing

Clinical and Genetic Analysis of ROP

Who this might be right for
Retinopathy of Prematurity
Oregon Health and Science University 2,000
Large-scale testing (Phase 3)Study completedNCT04636853
What this trial is testing

CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration

Who this might be right for
Retinitis PigmentosaDry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableStudy completedNCT03319524
What this trial is testing

Clinical and Genetic Testing of Patients With Usher Syndrome

Who this might be right for
Usher SyndromeCongenital DeafnessRetinitis Pigmentosa
Sensor Technology for Deafblind 28
Testing effectiveness (Phase 2)Study completedNCT02134457
What this trial is testing

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity (ROP)
University Hospital Freiburg 19
Large-scale testing (Phase 3)Study completedNCT03584165
What this trial is testing

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Who this might be right for
ChoroideremiaX-Linked Retinitis Pigmentosa
NightstaRx Ltd, a Biogen Company 277
Not applicableActive Not RecruitingNCT06517940
What this trial is testing

A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis Pigmentosa
Sumitomo Pharma America, Inc. 12
Not applicableStudy completedNCT01264276
What this trial is testing

Telemedicine Approaches to Evaluating Acute-phase ROP

Who this might be right for
Retinopathy of Prematurity
Children's Hospital of Philadelphia 269
Not applicableNo Longer AvailableNCT03672968
What this trial is testing

EAP_GS010_single Patient

Who this might be right for
Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
GenSight Biologics
Early research (Phase 1)Study completedNCT01521793
What this trial is testing

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Who this might be right for
LCA (Leber Congenital Amaurosis)RP (Retinitis Pigmentosa)
QLT Inc. 27
Not applicableActive Not RecruitingNCT05573984
What this trial is testing

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Who this might be right for
Retinitis PigmentosaEye Diseases, HereditaryRetinal Dystrophies+2 more
PYC Therapeutics 50
Not applicableTemporarily pausedNCT04639635
What this trial is testing

CNGB1 and Allied Disorders

Who this might be right for
Retinitis Pigmentosa Associated With CNGB1 Mutations
Columbia University 20
Testing effectiveness (Phase 2)Study completedNCT02386839
What this trial is testing

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)

Who this might be right for
Retinopathy of Prematurity (ROP)
Shire 76
Not applicableStudy completedNCT00811512
What this trial is testing

Fundus Changes in the Microphthalmy Eyes

Who this might be right for
Eye Diseases, Hereditary
Hospital de Olhos Sadalla Amin Ghanem 3
Not applicableUnknownNCT02090322
What this trial is testing

Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1

Who this might be right for
Retinopathy of Prematurity
Universidad Autonoma de San Luis Potosí 60
Next Page